Related Experiment Videos
Involvement of brain glutamate release in pyrogenic fever
1Department of Health Care Administration, Di Wan College of Management, Madou, Tainan, Taiwan, ROC.
Neuropharmacology
|October 31, 2001
Summary
Glutamate release in the organum vasculosum laminae terminalis (OVLT) plays a key role in fever development. Blocking NMDA receptors with MK801 or ketamine reduced fever and glutamate release in rabbits.
Area of Science:
- Neuroscience
- Physiology
- Pharmacology
Background:
- The precise mechanisms underlying fever genesis remain incompletely understood.
- The role of glutamate release in the organum vasculosum laminae terminalis (OVLT) during pyrogenic fever is unclear.
Purpose of the Study:
- To investigate the changes in OVLT glutamate concentrations during fever induced by staphylococcal enterotoxin A (SEA) in rabbits.
- To determine the involvement of glutamatergic pathways in the OVLT in fever development.
Main Methods:
- Microdialysis was used to measure extracellular glutamate concentrations in the OVLT of unanesthetized rabbits.
- Colonic temperatures were monitored simultaneously with glutamate levels during systemic or intra-OVLT administration of SEA, NMDA receptor blockers (MK801, ketamine), or saline.
- High-pressure liquid chromatography with a fluorescence detector was employed for glutamate quantification.
Main Results:
- Systemic SEA administration increased both OVLT glutamate concentrations and colonic temperatures, with glutamate levels rising slightly before body temperature.
- Pretreatment or posttreatment with MK801 or ketamine significantly attenuated SEA-induced glutamate release and fever.
- Direct injection of SEA or glutamate into the OVLT mimicked SEA-induced fever, which was also attenuated by NMDA receptor blockers.
Conclusions:
- Glutamatergic pathways within the OVLT region are implicated in the genesis of pyrogenic fever.
- NMDA receptor antagonists effectively reduce fever by inhibiting glutamate release in the OVLT.